• 1
    Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: 466.
  • 2
    Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 53343.
  • 3
    Koulibaly M, Kabba IS, Cissé A, Diallo SB, Diallo MB, Keita N, Camara ND, Diallo MS, Sylla BS, Parkin DM. Cancer incidence in Conakry, Guinea: first results from the cancer registry 1992–1995. Int J Cancer 1997; 70: 3945.
  • 4
    Echimane AK, Ahnoux AA, Adoubi I, Hien S, M'Bra K, D'Horpock A, Diomande M, Anongba D, Mensah-Adoh I, Parkin DM. Cancer incidence in Abidjan, Ivory Coast: first results from the cancer registry, 1995–1997. Cancer 2000; 89: 65363.
  • 5
    ParkinDM, FerlayJ, Hamdi-ChérifM, SitasF, ThomasJO, WabingaH, WhelanSL, eds. Cancer in Africa, epidemiology and prevention. Lyon: IARC Press, 2003.
  • 6
    CuradoMP, EdwardsB, ShinHR, StormH, FerlayJ, HeanueM, BoyleP, eds. Cancer incidence in five continents, vol. 9. Lyon: IARC Scientific Publications, 2007.
  • 7
    PercyC, Van HoltenV, MuirC, eds. International Classification of Diseases for Oncology, 2nd edn. Geneva: World Health Organization, 1992.
  • 8
    Bray F, Guilloux A, Sankila R, Parkin DM. Practical implications of imposing a new world standard population. Cancer Causes Control 2002; 13: 17582.
  • 9
    Chen JG, Zhu J, Parkin DM, Zhang YH, Lu JH, Zhu YR, Chen TY. Trends in the incidence of cancer in Qidong, China, 1978–2002. Int J Cancer 2006; 119: 144754.
  • 10
    ParkinDM, ChenVW, FerlayJ, GalceranJ, StormHH, WhelanSL, eds. Comparability and quality control in cancer registration. Lyon: IACR and IARC (WHO), IARC Technical Report No. 19, 1994.
  • 11
    Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953–2000. Int J Cancer 2005; 113: 97790.
  • 12
    SzkloM, NietoFJ, eds. Epidemiology: beyond the basics. Gaithersbury (MD): Aspen Publishers, 2000. 43840.
  • 13
    World Health Organization (WHO), International Union against Cancer (UICC). Global action against cancer. Geneva: WHO, 2003. 124.
  • 14
    Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 2009; 45: 75664.
  • 15
    IARC. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83: 11438.
  • 16
    B'chir F, Laouani A, Ksibi S, Arnaud MJ, Saguem S. Cigarette filter and the incidence of lung adenocarcinoma among Tunisian population. Lung Cancer 2007; 57: 2633.
  • 17
    Cox JD, Yesner RA. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis 1979; 120: 10259.
  • 18
    Wu AH, Henderson BE, Thomas DC, Mack TM. Secular trends in histologic types of lung cancer. J Natl Cancer Inst 1986; 77: 536.
  • 19
    Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ 2000; 321: 6659.
  • 20
    Duffy SW, Tabár L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002; 95: 45869.
  • 21
    Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ; National Evaluation Team for Breast Cancer Screening. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003; 361: 14117.
  • 22
    Ito Y, Ioka A, Tanaka M, Nakayama T, Tsukuma H. Trends in cancer incidence and mortality in Osaka, Japan: evaluation of cancer control activities. Cancer Sci 2009; 100: 239095.
  • 23
    Schmidt ME, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi N, Flesch-Janys D, Chang-Claude J. Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life. Cancer Epidemiol Biomarkers Prev 2008; 17: 340210.
  • 24
    Ben Abdallah M, Zehani S, Maalej M, Hsairi M, Hechiche M, Ben Romdhane K, Boussen H, Saadi A, Achour N, Ben Ayed F. Breast cancer in Tunisia: epidemiologic characteristics and trends in incidence. Tunis Med 2009; 87: 41725.
  • 25
    Popkin BM. The nutrition transition: an overview of world patterns of change. Nutr Rev 2004; 62: 1403.
  • 26
    Luo J, Hu FB. Time trends of obesity in pre-school children in China from 1989 to 1997. Int J Obes Relat Metab Disord 2002; 26: 5538.
  • 27
    Shu XO, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, Hebert JR, Ruan Z, Gao YT, Zheng W. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 2001; 94: 44955.
  • 28
    Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 1994; 52: 28598.
  • 29
    Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 92543.
  • 30
    Giovannucci E, Wu K. Cancers of the colon and rectum. In: SchottenfeldD, FraumeniJ, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 2006. 80929.
  • 31
    Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 276578.
  • 32
    Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009; 18: 168894.
  • 33
    Knai C, Suhrcke M, Lobstein T. Obesity in Eastern Europe: an overview of its health and economic implications. Econ Hum Biol 2007; 5: 392408.
  • 34
    Baillie K. Health implications of transition from a planned to a free-market economy—an overview. Obes Rev 2008; 9: 14650.
  • 35
    Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008; 122: 135767.
  • 36
    Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 38994.
  • 37
    Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska natives. Cancer 2007; 110: 211952.
  • 38
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology. Gastroenterology 2008; 134: 157095.
  • 39
    Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100: 167294.
  • 40
    Thompson IM, Ankerst DP. Prostate-specific antigen in the early detection of prostate cancer. CMAJ 2007; 176: 18538.
  • 41
    Andriole GL, Crawford ED, Grubb RL, III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 13109.
  • 42
    Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized european study. N Engl J Med 2009; 360: 13208.
  • 43
    La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 2010; 21: 132360.
  • 44
    Arbyn M, Autier P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 2007; 18: 142325.
  • 45
    Boffetta P, La Vecchia C. Neoplasms. In: DetelsR, BeagleholeR, LansangMA, Martin GullifordM. Oxford textbook of public health, 5th edn. New York: Oxford University Press, 2009. 9971020.
  • 46
    La Vecchia C. Oral contraceptives and ovarian cancer: an update, 1998–2004. Eur J Cancer Prev 2006; 15: 11724.
  • 47
    Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371: 30314.
  • 48
    El-Khwsky FS, Maghraby HK, Rostom YA, Abd El-Rahman AH. Multivariate analysis of reproductive risk factors for ovarian cancer in Alexandria, Egypt. J Egypt Natl Canc Inst 2006; 18: 304.
  • 49
    Tavani A, Gallus S, La Vecchia C, Dal Maso L, Negri E, Pelucchi C, Montella M, Conti E, Carbone A, Franceschi S. Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 2001; 91: 40711.